Table 1

Preoperative demographics/comorbidities for study population

eGFR >60CKD stage 3p Value
n84093
Age (years)61 (59 to 61)71 (69 to 73)<0.001
Gender (n; % male)546 (65)69 (74)0.08
BMI (kg/m2)26.7 (26.3 to 27.1)27.4 (26.3 to 28.5)0.24
Cancer (n (%))360 (43)34 (37)0.34
Ischaemic heart disease (n (%))156 (19)24 (26)0.08
Hypertension (n (%))252 (30)51 (55)<0.001
Heart failure (n (%))44 (5)4 (4)0.44
CVA/TIA (n (%))20 (2)4 (4)0.31
Diabetes mellitus (n (%))71 (9)20 (22)<0.001
Haemoglobin (g/dL)13.3 (13.0 to 13.5)12.9 (12.5 to 13.3)0.39
Albumin (g/L)44±444±40.81
Lung disease/COPD (n (%))98 (13)15 (16)0.49
Smoker (ex/present; n (%)291 (35)36 (39)0.55
β-blocker (n (%))85 (10)13 (14)0.20
Nitrate (n (%))24 (3)5 (5)0.16
ACE inhibitor (n (%))119 (14)26 (28)<0.001
Statin (n (%))184 (22)34 (37)<0.001
  • Data are shown as n (%) or mean (95% CIs).

  • BMI, body mass index; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebral vascular accident; eGFR, estimated glomerular filtration rate; TIA, transient ischemic attack.